News tagged with antisense oligonucleotide
Gene signal GS-101 data shows safe and effective inhibition of ophthalmic blood vessel growth
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide ...
Medicine & Health / Medications
Sep 01, 2009 |
not rated yet |
0
Researchers find possible treatment for spinal muscular atrophy
Spinal Muscular Atrophy is the second-leading cause of infant mortality in the world.
Medicine & Health / Diseases, Conditions, Syndromes
Jul 27, 2009 |
not rated yet |
0
Search results for antisense oligonucleotide
Study reports novel drug technology that boosts therapeutic proteins
(PhysOrg.com) -- A Miller School-led research team has created a groundbreaking drug technology platform that enables the body to increase its protein levels, a novel invention that potentially could usher in treatment for ...
Mar 25, 2012 |
5 / 5 (4) |
1
|
Biodegradable biopolymer nanoparticles hold promise for twin attack on breast cancer
Using a biodegradable polymer produced by a slime mold, a team of investigators from Cedars-Sinai Medical Center has created a multifunctional nanoparticle that attacks a key pathway involved in breast cancer in two different ...
Nanotechnology / Bio & Medicine
Mar 28, 2011 |
5 / 5 (2) |
0
|
Promising new 'antigene' therapy
Antigene therapy is a promising new treatment strategy that uses a DNA-based drug to pinpoint light energy to a target gene shutting down its activity. A review article published online ahead of print in Oligonucleotides, a peer ...
Oct 21, 2010 |
5 / 5 (3) |
0
Researchers demonstrate efficacy of antisense therapy for spinal muscular atrophy
The devastating, currently incurable motor-neuron disease spinal muscular atrophy (SMA) might soon be treated with tiny, chemically modified pieces of RNA called antisense oligonucleotides (ASOs).
Jul 12, 2010 |
not rated yet |
0
|
Heparanase-specific shRNA: A novel therapeutic strategy in human gastric cancer
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional ...
Nov 25, 2009 |
not rated yet |
0
Genetic source of muscular dystrophy neutralized
(PhysOrg.com) -- Researchers at the University of Rochester Medical Center have found a way to block the genetic flaw at the heart of a common form of muscular dystrophy. The results of the study, which were ...
Jul 16, 2009 |
5 / 5 (4) |
0
A new gene silencing platform -- silence is golden
A team of researchers led by Rutgers' Samuel Gunderson has developed a novel gene silencing platform with very significant improvements over existing RNAi approaches. This may enable the development and discovery of a new ...
Biology /
Feb 15, 2009 |
4 / 5 (1) |
0
A new gene silencing platform -- silence is golden
A team of researchers led by Rutgers' Samuel Gunderson has developed a novel gene silencing platform with very significant improvements over existing RNAi approaches. This may enable the development and discovery of a new ...
Biology /
Feb 08, 2009 |
4.7 / 5 (3) |
1
Scientists devise potential approach to treat spinal muscular atrophy
In the neuromuscular disease called spinal muscular atrophy, or SMA, a protein deficiency caused by a single gene mutation leads to serious damage in growing nerve cells and the muscles they control.
Medicine & Health / Medical research
Apr 05, 2008 |
5 / 5 (3) |
0
Researchers discover DNA shift never before seen in nature
A team of MIT researchers and others has discovered that bacteria employ a type of DNA modification never before seen in nature.
Dec 03, 2007 |
4.3 / 5 (36) |
0
List of search results for antisense oligonucleotide
